- Investing Ideas
- Canadian Pharmaceuticals & Biotech High Growth Potential Companies
Canadian Pharmaceuticals & Biotech High Growth Potential Companies
Results
15
Companies with a Future performance score of at least 3, ordered by Future performance score.
15 companies
Sernova Biotherapeutics
Market Cap: CA$58.4m
Operates as a clinical-stage biotechnology company in Canada.
SVA
CA$0.15
7D
7.1%
1Y
-11.8%
Spectral Medical
Market Cap: CA$413.7m
Focuses on the development and commercialization of products for the treatment of septic shock in the United States, Italy, Ireland, Russia, and internationally.
EDT
CA$1.38
7D
-2.8%
1Y
64.3%
Charlotte's Web Holdings
Market Cap: CA$91.5m
Engages in the farming, manufacturing, marketing, and sale of hemp-derived cannabidiol (CBD) and botanical-based wellness products in the United States.
CWEB
CA$0.57
7D
-14.9%
1Y
356.0%
Medexus Pharmaceuticals
Market Cap: CA$126.1m
Operates as a pharmaceutical company in Canada and the United States.
MDP
CA$3.91
7D
0.8%
1Y
37.7%
Cardiol Therapeutics
Market Cap: CA$180.1m
A clinical-stage life sciences company, focuses on the development of anti-fibrotic and anti-inflammatory therapies for the treatment of heart diseases.
CRDL
CA$1.57
7D
-7.1%
1Y
-18.2%
Vext Science
Market Cap: CA$64.4m
Through its subsidiaries, engages in integrated cannabis operations in the United States.
VEXT
CA$0.26
7D
0%
1Y
100.0%
High Tide
Market Cap: CA$290.9m
Engages in the cannabis retail business in Canada, the United States, and internationally.
HITI
CA$3.22
7D
-5.3%
1Y
0%
Cronos Group
Market Cap: CA$1.5b
A cannabinoid company, engages in the cultivation, production, distribution, and marketing of cannabis products in Canada, Israel, and internationally.
CRON
CA$3.85
7D
-2.0%
1Y
41.5%
Decibel Cannabis
Market Cap: CA$69.2m
An integrated cannabis company, engages in the cannabis cultivation, processing, and sale of cannabis flower products in Canada.
DB
CA$0.12
7D
-4.2%
1Y
64.3%
Organigram Global
Market Cap: CA$212.4m
Engages in the production and sale of cannabis and cannabis-derived products in Canada.
OGI
CA$1.48
7D
-5.7%
1Y
-20.2%
Covalon Technologies
Market Cap: CA$59.4m
Engages in the research, development, manufacturing, and marketing of medical products in infection management, advanced wound care, and surgical procedure areas in the United States, the Middle East, Canada, Latin America, Asia, and internationally.
COV
CA$2.10
7D
-3.2%
1Y
-11.4%
HLS Therapeutics
Market Cap: CA$138.4m
A specialty pharmaceutical company, acquires and commercializes pharmaceutical products for the treatment of psychiatric disorders and cardiovascular disease in Canada, the United States, and internationally.
HLS
CA$4.47
7D
-2.6%
1Y
-9.1%
Delivra Health Brands
Market Cap: CA$3.6m
Through its subsidiaries, engages in the health and wellness consumer packaged goods business worldwide.
DHB
CA$0.12
7D
-20.0%
1Y
-40.0%
Trulieve Cannabis
Market Cap: CA$2.7b
Operates as a cannabis retailer in the United States.
TRUL
CA$16.45
7D
28.7%
1Y
204.6%
Knight Therapeutics
Market Cap: CA$845.3m
Focuses on acquiring, in-licensing, out-licensing, marketing, and commercializing prescription pharmaceutical products in Canada and Latin America.
GUD
CA$8.61
7D
5.1%
1Y
43.5%